世界の血液型試薬市場:エンドユーザー別、地域別...市場調査レポートについてご紹介

【英文タイトル】Blood Grouping Reagents Market by End-users and Geography - Forecast and Analysis 2020-2024

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
• Value chain analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2019
• Market size and forecast 2019-2024
• Market Outlook
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY END-USER
• Market segmentation by end-user
• Comparison by end-user
• Hospitals and blood banks – Market size and forecast 2019-2024
• Clinical laboratories – Market size and forecast 2019-2024
• Academic and research institutes – Market size and forecast 2019-2024
• Market opportunity by end-user
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2019-2024
• Europe – Market size and forecast 2019-2024
• Asia – Market size and forecast 2019-2024
• ROW – Market size and forecast 2019-2024
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges s
PART 11: MARKET TRENDS
• Emergence of social media marketing
• Advancement in technology
• Increasing penetration of healthcare facilities
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Bio-Rad Laboratories Inc.
• DIAGAST
• Grifols SA
• Immucor Inc.
• Merck KGaA
• Novacyt SA
• Ortho-Clinical Diagnostics Inc.
• Quotient Ltd.
• Rapid Labs Ltd.
• Ybio Inc.
PART 14: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO


Exhibit 01: Vendors: Key offerings
Exhibit 02: Global healthcare market
Exhibit 03: Segments of global healthcare market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2019
Exhibit 18: End-user – Market share 2019-2024 (%)
Exhibit 19: Comparison by end-user
Exhibit 20: Hospitals and blood banks – Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Hospitals and blood banks – Year-over-year growth 2020-2024 (%)
Exhibit 22: Clinical laboratories – Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Clinical laboratories – Year-over-year growth 2020-2024 (%)
Exhibit 24: Academic and research institutes – Market size and forecast 2019-2024 ($ millions)
Exhibit 25: Academic and research institutes – Year-over-year growth 2020-2024 (%)
Exhibit 26: Market opportunity by end-user
Exhibit 27: Customer landscape
Exhibit 28: Market share by geography 2019-2024 (%)
Exhibit 29: Geographic comparison
Exhibit 30: North America – Market size and forecast 2019-2024 ($ millions)
Exhibit 31: North America – Year-over-year growth 2020-2024 (%)
Exhibit 32: Top 3 countries in North America
Exhibit 33: Europe – Market size and forecast 2019-2024 ($ millions)
Exhibit 34: Europe – Year-over-year growth 2020-2024 (%)
Exhibit 35: Top 3 countries in Europe
Exhibit 36: Asia – Market size and forecast 2019-2024 ($ millions)
Exhibit 37: Asia – Year-over-year growth 2020-2024 (%)
Exhibit 38: Top 3 countries in Asia
Exhibit 39: ROW – Market size and forecast 2019-2024 ($ millions)
Exhibit 40: ROW – Year-over-year growth 2020-2024 (%)
Exhibit 41: Top 3 countries in ROW
Exhibit 42: Key leading countries
Exhibit 43: Market opportunity
Exhibit 44: Impact of drivers and challenges
Exhibit 45: Vendor landscape
Exhibit 46: Landscape disruption
Exhibit 47: Vendors covered
Exhibit 48: Vendor classification
Exhibit 49: Market positioning of vendors
Exhibit 50: Bio-Rad Laboratories Inc. – Vendor overview
Exhibit 51: Bio-Rad Laboratories Inc. – Product segments
Exhibit 52: Bio-Rad Laboratories Inc. – Organizational developments
Exhibit 53: Bio-Rad Laboratories Inc. – Geographic focus
Exhibit 54: Bio-Rad Laboratories Inc. – Segment focus
Exhibit 55: Bio-Rad Laboratories Inc. – Key offerings
Exhibit 56: DIAGAST – Vendor overview
Exhibit 57: DIAGAST – Business segments
Exhibit 58: DIAGAST – Key offerings
Exhibit 59: Grifols SA – Vendor overview
Exhibit 60: Grifols SA – Product segments
Exhibit 61: Grifols SA – Organizational developments
Exhibit 62: Grifols SA – Geographic focus
Exhibit 63: Grifols SA – Segment focus
Exhibit 64: Grifols SA – Key offerings
Exhibit 65: Immucor Inc. – Vendor overview
Exhibit 66: Immucor Inc. – Business segments
Exhibit 67: Immucor Inc. – Organizational developments
Exhibit 68: Immucor Inc. – Key offerings
Exhibit 69: Merck KGaA – Vendor overview
Exhibit 70: Merck KGaA – Business segments
Exhibit 71: Merck KGaA – Organizational developments
Exhibit 72: Merck KGaA – Geographic focus
Exhibit 73: Merck KGaA – Segment focus
Exhibit 74: Merck KGaA – Key offerings
Exhibit 75: Novacyt SA – Vendor overview
Exhibit 76: Novacyt SA – Business segments
Exhibit 77: Novacyt SA – Organizational developments
Exhibit 78: Novacyt SA – Geographic focus
Exhibit 79: Novacyt SA – Segment focus
Exhibit 80: Novacyt SA – Key offerings
Exhibit 81: Ortho-Clinical Diagnostics Inc. – Vendor overview
Exhibit 82: Ortho-Clinical Diagnostics Inc. – Business segments
Exhibit 83: Ortho-Clinical Diagnostics Inc. – Key offerings
Exhibit 84: Quotient Ltd. – Vendor overview
Exhibit 85: Quotient Ltd. – Business segments
Exhibit 86: Quotient Ltd. – Geographic focus
Exhibit 87: Quotient Ltd. – Key offerings
Exhibit 88: Rapid Labs Ltd. – Vendor overview
Exhibit 89: Rapid Labs Ltd. – Product segments
Exhibit 90: Rapid Labs Ltd. – Key offerings
Exhibit 91: Ybio Inc. – Vendor overview
Exhibit 92: Ybio Inc. – Product segments
Exhibit 93: Ybio Inc. – Key offerings
Exhibit 94: Validation techniques employed for market sizing
Exhibit 95: Definition of market positioning of vendors


【レポート販売概要】

■ タイトル:世界の血液型試薬市場:エンドユーザー別、地域別
■ 英文:Blood Grouping Reagents Market by End-users and Geography - Forecast and Analysis 2020-2024
■ 発行日:2019年11月14日
■ 調査会社:Technavio
■ 商品コード:IRTNTR40141
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。